These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 170655)

  • 1. [Changes in the enteroviruses, their antibodies and poliomyelitis in Chile during the last 20 years].
    Contreras G
    Rev Chil Pediatr; 1975; 46(1):69-76. PubMed ID: 170655
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba.
    Ochoa EG; Lago PM
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):381-9. PubMed ID: 2828465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 6. The status of poliomyelitis in Venezuela.
    Echezuría E
    Bull Pan Am Health Organ; 1974; 8(1):66-71. PubMed ID: 4371606
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against polio. Inactivated polio vaccine used in The Netherlands and Burkina Faso.
    Rümke HC
    Trop Geogr Med; 1993; 45(5):202-5. PubMed ID: 8279056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Poliomyelitis in New Caledonia. Virological and serological data. Pre-immune status and post-vaccinal seroconversion. Prophylactic strategy].
    Panon G; Louis JP; Le Gonidec G
    Bull Soc Pathol Exot Filiales; 1985; 78(3):321-33. PubMed ID: 2992831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-poliomyelitis campaign in Taiwan.
    Hsu ST; Lin SY
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):140-6. PubMed ID: 4332824
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 12. [Poliomyelitis control program in Brasil: study of immunity levels].
    Bastos NC; De Carvalho Filho ES; Schatzmayr H; Homma A; Chaves J
    Bol Oficina Sanit Panam; 1973 Dec; 75(6):511-22. PubMed ID: 4273161
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO
    N Engl J Med; 1977 Aug; 297(5):249-53. PubMed ID: 195207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 15. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Poliomyelitis in New Caledonia: epidemiological data, post-vaccinal seroconversion, prophylactic strategy].
    Louis JP; Panon G; Le Gonidec G
    Med Trop (Mars); 1985; 45(3):223-33. PubMed ID: 2999557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 20. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.